Posted by & filed under Company Analysis, Growth & Valuation, Management Issues, Personal Finance.

Description: Drugstore chains and pharmacy-benefit managers are likely at risk, Wall Street analysts say


Date: Oct 14, 2017


Questions for discussion:

  • Do you think this move would be good for the firm?
  • What are the pros and cons from an investor’s point of view?

Leave a Reply

Your email address will not be published. Required fields are marked *